<div style="width: 100%; height: 500px; margin: 20px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; position: relative; z-index: 1;">
    <iframe 
        src="https://s.tradingview.com/widgetembed/?symbol=LLY&interval=D&theme=Light&style=1&locale=en&toolbarbg=f1f3f6&hideideas=1&studies=%5B%22MASimple%40tv-basicstudies%22%2C%20%22MACD%40tv-basicstudies%22%5D" 
        style="width: 100%; height: 100%; border: 0; display: block;" 
        scrolling="no" 
        allowtransparency="true" 
        frameborder="0">
    </iframe>
</div>

📊 TECHNICAL DEEP DIVE (Multi-Timeframe Analysis) A. TREND STRUCTURE (The "Big Picture") - MA System: The price is above the Weekly MA20 and Daily MA20, indicating a bullish major trend. Specifically, the Weekly MA20 is at 1071.65, and the Daily MA20 is at 1074.56, with the current price at 1073.32. - Bollinger Bands: The price is not breaking the Upper Band or hugging the Lower Band, but the Band Width is relatively stable, with a width of 5.52 on the daily chart and 2.07 on the intraday chart. B. MOMENTUM & MONEY FLOW (The "Engine") - MACD: The Weekly MACD Histogram is positive at 13.708, indicating accelerating momentum, while the Daily MACD Histogram is -3.333 and the intraday MACD Histogram is -0.462, suggesting fading momentum. - RSI & KDJ: The RSI(14) is 54.20 on the daily chart and 48.26 on the intraday chart, indicating a neutral position, while the KDJ (J) is 32.03 on the daily chart and 56.54 on the intraday chart, suggesting potential trend reversals. - OBV (Volume): Not explicitly provided, but we can infer from the ATR and volatility data that volume is relatively stable. - ATR (Volatility): The ATR is 29.44 on the daily chart and 8.69 on the intraday chart, indicating moderate volatility. C. VERDICT: The technical outlook for Eli Lilly is bullish in the long term, with a potential short-term pullback due to fading momentum. 🎯 QUANT SCORE (2-4 Weeks View) [LONG SCORE: 60] [SHORT SCORE: 40] 🚀 STRATEGY & RISK MANAGEMENT - Action: Enter with caution, considering the potential short-term pullback. - Levels: Support at 1042.08 (Lower Bollinger Band) and resistance at 1101.22 (Upper Bollinger Band). - Option Play: Consider buying options or selling spreads, given the moderate volatility and relatively low historical volatility rank (15.8). 🧐 ASSET PROFILE (Fundamental Context) - Identity: Eli Lilly (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets human pharmaceutical products, with a focus on diabetes, oncology, immunology, and neuroscience. - Status/Holdings: As a leading player in the pharmaceutical industry, Eli Lilly has a strong portfolio of products and a significant presence in the global market. - Business Model: Eli Lilly's business model is centered around the research, development, and commercialization of pharmaceutical products, with a focus on innovative medicines and a strong pipeline of potential new products. - Recent Profitability/Earnings Trend: Eli Lilly has shown a positive net income growth trend in recent years, driven by the success of its key products and a strong pipeline of new medicines. - PE/Valuation Status: With a historical volatility rank of 15.8, indicating relatively low volatility, and a PE ratio that is relatively in line with the industry average, Eli Lilly's valuation can be considered roughly fair, neither extremely expensive nor cheap.